Capital Advisors Inc’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $817K | Buy |
2,255
+2
| +0.1% | +$685 | 0.01% | 181 |
|
|
2026
Q1 | $793K | Buy |
2,253
+122
| +6% | +$43.5K | 0.01% | 180 |
|
|
2025
Q4 | $698K | Buy |
2,131
+7
| +0.3% | +$2.22K | 0.01% | 183 |
|
|
2025
Q3 | $599K | Sell |
2,124
-7
| -0.3% | -$2.03K | 0.01% | 190 |
|
|
2025
Q2 | $595K | Buy |
2,131
+4
| +0.2% | +$1.13K | 0.01% | 189 |
|
|
2025
Q1 | $663K | Sell |
2,127
-277
| -12% | -$81.8K | 0.01% | 170 |
|
|
2024
Q4 | $627K | Buy |
2,404
+278
| +13% | +$82.5K | 0.01% | 181 |
|
|
2024
Q3 | $685K | Sell |
2,126
-439
| -17% | -$144K | 0.01% | 173 |
|
|
2024
Q2 | $801K | Buy |
2,565
+67
| +3% | +$19.7K | 0.02% | 159 |
|
|
2024
Q1 | $710K | Buy |
2,498
+2
| +0.1% | +$585 | 0.02% | 170 |
|
|
2023
Q4 | $719K | Sell |
2,496
-440
| -15% | -$120K | 0.02% | 178 |
|
|
2023
Q3 | $789K | Sell |
2,936
-807
| -22% | -$201K | 0.02% | 144 |
|
|
2023
Q2 | $831K | Buy |
3,743
+674
| +22% | +$156K | 0.02% | 148 |
|
|
2023
Q1 | $742K | Sell |
3,069
-199
| -6% | -$48.8K | 0.02% | 151 |
|
|
2022
Q4 | $858K | Sell |
3,268
-1,549
| -32% | -$415K | 0.02% | 146 |
|
|
2022
Q3 | $1.21M | Buy |
4,817
+60
| +1% | +$14.5K | 0.04% | 119 |
|
|
2022
Q2 | $1.16M | Buy |
4,757
+74
| +2% | +$18.1K | 0.03% | 120 |
|
|
2022
Q1 | $1.13M | Buy |
4,683
+522
| +13% | +$120K | 0.03% | 119 |
|
|
2021
Q4 | $936K | Sell |
4,161
-3
| -0.1% | -$633 | 0.03% | 130 |
|
|
2021
Q3 | $885K | Buy |
4,164
+2,096
| +101% | +$482K | 0.03% | 129 |
|
|
2021
Q2 | $504K | Sell |
2,068
-20
| -1% | -$4.92K | 0.02% | 166 |
|
|
2021
Q1 | $519K | Buy |
2,088
+970
| +87% | +$231K | 0.02% | 152 |
|
|
2020
Q4 | $257K | Buy |
1,118
+205
| +22% | +$47.3K | 0.01% | 179 |
|
|
2020
Q3 | $232K | Buy |
+913
| New | +$226K | 0.01% | 175 |
|
|
2019
Q1 | – | Sell |
-1,609
| Closed | -$313K | – | 134 |
|
|
2018
Q4 | $313K | Buy |
1,609
+200
| +14% | +$39K | 0.02% | 149 |
|
|
2018
Q3 | $292K | Hold |
1,409
| – | – | 0.02% | 151 |
|
|
2018
Q2 | $260K | Sell |
1,409
-50
| -3% | -$8.84K | 0.02% | 158 |
|
|
2018
Q1 | $249K | Sell |
1,459
-13
| -0.9% | -$2.39K | 0.01% | 166 |
|
|
2017
Q4 | $256K | Buy |
1,472
+56
| +4% | +$9.91K | 0.02% | 174 |
|
|
2017
Q3 | $264K | Sell |
1,416
-350
| -20% | -$62K | 0.02% | 164 |
|
|
2017
Q2 | $304K | Sell |
1,766
-76,582
| -98% | -$12.5M | 0.02% | 159 |
|
|
2017
Q1 | $12.9M | Buy |
78,348
+3,084
| +4% | +$512K | 0.84% | 37 |
|
|
2016
Q4 | $11M | Buy |
75,264
+3,225
| +4% | +$485K | 0.77% | 39 |
|
|
2016
Q3 | $12M | Sell |
72,039
-280
| -0.4% | -$47.3K | 1.8% | 13 |
|
|
2016
Q2 | $11M | Buy |
72,319
+2,442
| +3% | +$380K | 1.7% | 13 |
|
|
2016
Q1 | $10.5M | Buy |
69,877
+1,936
| +3% | +$288K | 1.71% | 12 |
|
|
2015
Q4 | $11M | Buy |
67,941
+1,271
| +2% | +$200K | 1.93% | 10 |
|
|
2015
Q3 | $9.22M | Buy |
66,670
+1,463
| +2% | +$231K | 1.66% | 15 |
|
|
2015
Q2 | $10M | Buy |
65,207
+1,660
| +3% | +$266K | 1.72% | 17 |
|
|
2015
Q1 | $10.2M | Buy |
63,547
+1,885
| +3% | +$297K | 1.25% | 19 |
|
|
2014
Q4 | $9.82M | Sell |
61,662
-850
| -1% | -$132K | 1.82% | 13 |
|
|
2014
Q3 | $8.78M | Sell |
62,512
-1,762
| -3% | -$230K | 1.8% | 16 |
|
|
2014
Q2 | $7.61M | Buy |
64,274
+1,340
| +2% | +$155K | 1.47% | 24 |
|
|
2014
Q1 | $7.76M | Buy |
62,934
+105
| +0.2% | +$12.7K | 1.69% | 16 |
|
|
2013
Q4 | $7.17M | Sell |
62,829
-70
| -0.1% | -$7.96K | 1.58% | 22 |
|
|
2013
Q3 | $7.04M | Buy |
62,899
+1,180
| +2% | +$128K | 1.69% | 19 |
|
|
2013
Q2 | $6.09M | Buy |
+61,719
| New | +$6.4M | 1.64% | 22 |
|
Other funds holding AMGN
FFM
Capital Advisors Inc's AMGN Position: Q2 2026 in Review
Capital Advisors Inc increased its Amgen (AMGN) stake by 0.09% in Q2 2026, buying an estimated $685 and bringing the position to 2,255 shares worth $817K. The position accounts for 0.01% of the portfolio, ranked #181.
Capital Advisors Inc first reported a position in AMGN in Q2 2013 and has held it in 47 quarters since. The position peaked at $12.9M in Q1 2017. 1,404 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Capital Advisors Inc held 2,255 shares of Amgen worth $817K as of Q2 2026.
- Capital Advisors Inc bought 2 Amgen shares in Q2 2026, an estimated $685.
- Amgen made up 0.01% of Capital Advisors Inc's portfolio in Q2 2026, its #181 holding.
- Capital Advisors Inc first reported a position in Amgen in Q2 2013 and has held it in 47 quarters since.
- Capital Advisors Inc's Amgen position peaked at $12.9M in Q1 2017.
- 1,404 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Capital Advisors Inc's 13F filing for Q2 2026, filed 23 Jul 2026.